ESHG 2024

Discover the Latest Advances in Variant Classification and Interpretation Tools at Golden Helix's Booth at ESHG 2024

Join Golden Helix at the European Human Genetics (ESHG) 2024 conference and discover the latest advances in genetic research. This premier event brings together leading researchers, clinicians, and industry experts to share their insights on cutting-edge topics in medical genetics.

At Golden Helix's booth, you'll have the opportunity to learn more about our advanced genetic analysis tools. Our comprehensive suite of software solutions includes VarSeq, VS-CNV, VSClinical, VSPipeline, and VSWarehouse, which provide powerful and user-friendly options for genomic analysis and interpretation based on the ACMG and AMP Guidelines. We will also be offering demos on our latest pharmacogenomics solution, VSPGx.

Stop by our booth to see a live demo of our software, learn about the latest features, and discuss how our tools can enhance your genetic research. Plus, by visiting our booth for a demo, you'll receive one of our famous t-shirts.

Don't miss this chance to discover the latest in genetic analysis tools and meet with our expert team at ESHG 2024. We look forward to seeing you there!

Find us in Booth #428

Come check out our exciting product demos and meet with our team to discuss your needs in Booth #1313. Plus, don't miss the chance to score brand new t-shirts designed exclusively for ESHG demo attendees! See you there!

ESHG Booth #428 2024

Demo Schedule

Don't miss out on the chance to experience our advanced software solutions in action! Our expert Field Application Scientist team will be leading short software demos throughout the conference exhibition at our booth. Stop by to see how our powerful and user-friendly tools can help take your genomic analysis and interpretation to the next level.

  • Saturday, June 1:
    • 10:10 - PGx: Pharmacogenomics Workflow
    • 12:10 - VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR
    • 12:40 - Whole Genome Analysis with Long Read Data
    • 13:10 - Calling CNV with Twist Exome 2.0
    • 13:30 - NGS Enterprise Capabilities - Automation, Warehousing, Continuous Improvement 16:10 - Carrier Status Analysis in VarSeq
    • 18:10 - Somatic NGS Workflow with VarSeq - Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
  • Sunday, June 2:
    • 10:10 - Somatic NGS Workflow with VarSeq - Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
    • 12:10 - PGx: Pharmacogenomics Workflow
    • 12:40 - VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR 13:10 - Whole Genome Analysis with Long Read Data
    • 13:40 - Carrier Status Analysis in VarSeq
    • 15:40 - NGS Enterprise Capabilities - Automation, Warehousing, Continuous Improvement
    • 16:40 - Calling CNV with Twist Exome 2.0
  • Monday, June 3:
    • 10:10 - Carrier Status Analysis in VarSeq
    • 12:00 - 13:00 Corporate Satellite Talk (Room: New York 1): Golden Helix: A Clinical Interpretation Solution for Next-Generation Sequencing
    • 13:30 - VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR
    • 15:40 - PGx: Pharmacogenomics Workflow
    • 16:10 - Calling CNV with Twist Exome 2.0
    • 16:40 - NGS Enterprise Capabilities - Automation, Warehousing, Continuous Improvement

Corporate Satellite Talk

Golden Helix - A Clinical Interpretation Solution for Next Generation Sequencing Labs

Monday, June 3, 12:00 - 13:00, Room: New York 1

Presented by: Dr. Andreas Scherer, President and CEO & Nathan Fortier, PhD, Golden Helix Director of Research, Jennifer Dankoff, PhD, Field Application Scientist

Guest Speaker: Tina Han, Director of Applications & Business Development Twist Biosciences

Guest Speaker: David Stucki, Field Application Support Manager, PacBio

Join us for an insightful discussion on our latest advancements in the clinical interpretation  of next-generation sequencing data. Discover our high quality variant analysis and interpretation capabilities that scale efficiently. Implement ACMG and AMP guidelines for variant interpretation, directly call CNVs in target regions, exomes and whole genomes, and utilize repeatable clinical interpretation workflows. Recently, we unveiled our pharmacogenomics solution VSPGx, based on the CPIC guidelines. We will share some of the VSPGx capabilities in further detail.

Stay Connected With Us at ESHG

Follow us on X

Stay up to date on all the latest news and happenings by following us on social media. Find us on Facebook, LinkedIn, or X.